CureVac is a Tübingen-based messenger-RNA biotechnology company founded in 2000. Following its acquisition by BioNTech, it operates as a BioNTech subsidiary focused on mRNA research and development.
| Business Model | Commerce |
|---|---|
| Legal Name | CureVac N.V. |
| Company Operating Status | Acquired |
| Full Address | 250 Summer St 3rd Fl Boston, MA 02210, USA |
| Previous Name | CureVac B.V. |
| Stock Symbol | CVAC |
| Ticker Symbol | CVAC |
| Wellfound ID | curevac |
| Wikidata ID | Q1144473 |
Email and phone for CureVac are available to signed-in members of CliffBio.
Sign in to view